Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-THP-PSMA PET/CT in Prostate Cancer
NCT03617588Phase 2Completed
- Sponsor
- Theragnostics
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of gallium-68 THP-PSMA in prostate cancer (PCa), sponsored by Theragnostics. Started Jun 2018; status: completed.
02
Drugs
gallium-68 THP-PSMA
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03617588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617588.